Call us 24/7

Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center Achieves Re-Certification from the American Society of Clinical Oncology (ASCO) for Providing High-Quality Cancer Care

CTCA Chicago | January 19, 2018

Cancer Treatment Centers of America at Midwestern Regional Medical Center has received re-certification by the QOPI® Certification Program (QCP™), an affiliate of the American Society of Clinical Oncology (ASCO®). QCP™ builds on ASCO’s Quality Oncology Practice Initiative (QOPI®), providing a three-year certification for outpatient hematology-oncology practices that meet nationally recognized standards for high-quality cancer care.  

QOPI is a voluntary, self-assessment and improvement program launched by ASCO in 2006 to help hematology-oncology and medical oncology practices assess the quality of the care they provide to patients. The QCP was launched in January 2010. To date there are more than 1,000 US hematology-oncology practices registered, with more than 290 currently certified.  This is the first program of its kind for oncology in the United States. Oncologists can achieve certification by meeting the highest standards of care.

"Receiving the QOPI re-certification from ASCO is an achievement that means a great deal to everyone affiliated with our hospital," said Scott Jones, CEO and president of CTCA at Midwestern. "As a multidisciplinary healthcare team working together for one common goal – the delivery of high-quality, compassionate cancer care – we are dedicated to the patients who entrust us with their lives.”

CTCA at Midwestern first achieved certification in 2014. In applying for re-certification, CTCA at Midwestern participated in a voluntary comprehensive site assessment against clearly specified standards that are consistent with national guidelines and was successful in meeting the standards and objectives of QCP.

“ASCO’s QOPI Certification demonstrates an oncology practice’s dedication to providing high-quality care to patients with cancer,” said ASCO President Bruce E. Johnson, MD, FASCO. “The certification process is rigorous and by successfully completing it, providers put into practice their commitment to quality and safety excellence and continuous optimization of their processes.”

To become QOPI certified, practices have to submit an evaluation of their entire practice and documentation standards. The QCP staff and steering group members then verify through on-site inspection that the evaluation and documents are correct and that the practice meets core standards in areas of:

  • Treatment planning
  • Staff training and education
  • Chemotherapy orders and drug preparation
  • Patient consent and education
  • Safe chemotherapy administration
  • Monitoring and assessment of patient well-being.

QOPI® and the QCP™ are projects dedicated to innovative quality improvement programs. For more information, please visit: http://www.instituteforquality.org/qopi-qcp.

About ASCO

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.

About QOPI Certification Program LLC

QOPI Certification Program LLC is an ASCO affiliate dedicated to recognizing exemplary commitment to safety and quality in oncology patient care. Practices that have achieved QOPI® Certification have scored well on key QOPI® quality measures and have met chemotherapy safety standards established by ASCO and the Oncology Nursing Society in various areas of treatment and chemotherapy safety.